Biopharma BD teams play a critical role in shaping a company’s future pipeline. Their work spans competitive benchmarking, program assessment, and commercial forecasting — all while tracking an unprecedented wave of global pharmaceutical innovation.
Join our upcoming webinar to learn how AI augments BD teams to intelligently streamline key work, thus enabling them to meet growing demands for in-licensed assets, without increasing headcount.
In this session, we'll cover:
Best practices from top BD and search & evaluation teams
Industry shifts driving demand for in-licensed assets
How AI helps teams:
Identify and prioritize high-value assets
Benchmark competitors and assess scientific merit
Diligence more assets faster — including global ones
We hope to see you there!
Register here:
https://vibebio.com/resources/events/bottlenecks-breakthroughs-bdnl/